Krawczyk, P.; Szreder, B. .; Chodań, T. .; Lewicka, M.; Łapaj, M.; Pietrzyk, P.; Ślusarczyk, J.; Stanek, N.; Noweta, Z.; Jagiełło, A. THE EFFICACY AND SAFETY OF GLECAPREVIR PIBRENTASVIR THERAPY IN THE TREATMENT OF HCV INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE – A REVIEW OF CURRENT LITERATURE. IJITSS 2026, 1 (2(50). https://doi.org/10.31435/ijitss.2(50).2026.5234.